Analysts' Opinions Are Mixed on These Healthcare Stocks: 60 Degrees Pharmaceuticals, Inc. (SXTP), GoodRx Holdings (GDRX) and Dianthus Therapeutics (DNTH)
Dianthus Therapeutics Analyst Ratings
Dianthus Therapeutics Analyst Ratings
Dianthus Therapeutics (DNTH) Gets a Buy From Wedbush
Wedbush Adjusts Dianthus Therapeutics' Price Target to $38 From $33, Keeps Outperform Rating
Dianthus Therapeutics Analyst Ratings
Dianthus Therapeutics Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Xenetic Biosciences (XBIO) and Dianthus Therapeutics (DNTH)
Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), Dianthus Therapeutics (DNTH) and Eli Lilly & Co (LLY)
Dianthus Therapeutics Analyst Ratings
Dianthus Therapeutics Analyst Ratings
Analysts' Top Healthcare Picks: Siemens Healthineers AG (SEMHF), Dianthus Therapeutics (DNTH)
Dianthus Therapeutics Analyst Ratings
Dianthus Therapeutics Analyst Ratings
Dianthus Therapeutics Analyst Ratings
Magenta Therapeutics (MGTA) Receives a Hold From H.C. Wainwright
Analysts' Opinions Are Mixed on These Healthcare Stocks: Agenus (AGEN), EyePoint Pharmaceuticals (EYPT) and Magenta Therapeutics (MGTA)
Magenta Therapeutics Analyst Ratings
BTIG Lowers Price Target on Magenta Therapeutics to $3 From $6, Maintains Buy Rating
Magenta Therapeutics Analyst Ratings
No Data